Ticker delayed 20 minutes
Avg Daily Volume: 2,698,500 Market Cap: 11.75B
Sector: None Short Interest: None
EARNINGS EXPECTATIONS:
THIS QTR: EPS: 0/share REV: 1,110/M
___________________________________________________________
LAST QTR: EPS: NA/share ACTUAL: NA/share (NEW IPO)
____________________________________________________________
NEXT QTR: EPS: -.11/share REV: 1,110/M
______________________________________________________
FULL YR: EPS: 0/share REV: 4,730/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: NA % OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -7.94, NA, NA
POTENTIAL JUMP MOVE: 10-15%
Links To Latest News and Headlines
By Jeff Simmons, President & CEO at Elanco NORTHAMPTON, MA / ACCESS Newswire / March 5, 2026 / From the McDonald’s Golden Arches to the Nike Swoosh, these brands have loyal customer bases that often form emotional attachments to the brand. The same …
Chewy (CHWY) concluded the recent trading session at $25.51, signifying a -4.96% move from its prior day’s close.
Chewy is expanding beyond pet e-commerce into vet clinics, telehealth, insurance and ads, aiming to deepen engagement, boost retention and support long-term margin growth.
Chewy (NYSE:CHWY) has appointed Christopher S. Deppe as Chief Financial Officer. Deppe brings extensive finance leadership experience, including senior roles at Amazon and in corporate operations. The CFO transition is viewed as a material corporate event for Chewy’s financial management and planning. Chewy operates an online pet products and services business, a segment that has attracted attention as consumers increasingly buy pet food, supplies, and medications through digital channels…
NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion NDT Pharmaceuticals, Inc.’s (OTC: NDTP) wholly owned subsidiary, Good Salt Life, Inc., is currently leveraging its presence across some of the world’s largest digital marketplaces, including Amazon, Chewy.com, and Walmart – www.goodsaltlife.com & www.ndtpharmaceuticals.com ATHENS, Ga., March 03, 2026 (GLOBE NEWSWIRE) — NDT Pharmaceuticals, Inc. (OTC: NDTP) (“Company”),
StockJumpers analysis and trade plans are uploaded generally 1 HOUR (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.